Stone Pharmaceutical Group 2 heavy-weight varieties have been over-evaluated

Medicine Network October 29 - October 26, the Official Website of the State Drug Administration shows that Stone Pharmaceutical Group's Nofluosa star tablets, cephalospora capsules through a consistent evaluation.
2019, sales of nofluorosa star and cephalospora ding in China's public medical institutions will be 130 million yuan and 370 million yuan, respectively, according to data from china's 100 million meters intranet.
to date, a total of 34 varieties of Stone Pharmaceutical Group have passed/treated with consistency evaluation.
is a quinoxone antibiotic and is suitable for urinary tract infections, gonorrhea, prostatitis, intestinal infections and typhoid and other salmonella infections caused by sensitive bacteria. according to
meters of intranet data, in 2019 China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminal Sales of more than 130 million yuan, tablets accounted for 7.16 percent of the market share.
of the internal network consistency evaluation database shows that nofluorosa star has three enterprises have been evaluated.
Zhejiang Pharmaceutical's Nofluorosa star tablets, Yantai Wanrun Pharmaceuticals' Nofluorosa star capsules are the first to be evaluated, Stone Pharmaceutical Group's Nofluosa star tablets for the second review.
Nofluoxa star evaluation source: Mienet consistency evaluation database cephalosporin belongs to the first generation of cephalosporins, suitable for acute pharyngitis caused by sensitive bacteria, tonsillitis, otitis media, bronchitis and pneumonia and other respiratory infections, genitourinary tract infections and skin soft tissue infections.
2019, China's public medical institutions terminal cephalospora sales of more than 370 million yuan, capsules accounted for 84.43 percent of the market share.
cephalospora as the second batch of harvested varieties.
of 2000 meters net consistency evaluation database shows that the current cephalospora ding capsule has 9 enterprises have been evaluated, Xinhua Pharmaceuticals for the first evaluation of the variety of enterprises.
cephalosporine capsule evaluation source: Mi net consistency evaluation database Minet data show that a total of 34 varieties of stone pharmaceutical group through / assimilated through consistency evaluation, of which 13 are the first over-evaluation, gremethyl dispersion tablets, hydrochloric acid renitin capsules, injected boron zomi, hydroxysporine tablets, hydrochloric acid quemado tablets 5 varieties for exclusive evaluation.
source: MiNet Database, NMPA